These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6604733)

  • 1. Effect of renal function on plasma levels of bone Gla-protein.
    Delmas PD; Wilson DM; Mann KG; Riggs BL
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1028-30. PubMed ID: 6604733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma bone Gla protein concentrations in healthy adults. Dependence on sex, age, and glomerular filtration.
    Johansen JS; Thomsen K; Christiansen C
    Scand J Clin Lab Invest; 1987 Jun; 47(4):345-50. PubMed ID: 3496655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation.
    Epstein S; Traberg H; Raja R; Poser J
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1253-6. PubMed ID: 3889031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of bone Gla-protein in normal humans and in patients with chronic renal failure.
    Sugimoto K; Dohi Y; Dohi K; Yonemasu K; Fujimoto J; Kanauchi M; Yamanaka F; Moriyama T; Ishikawa H
    Miner Electrolyte Metab; 1987; 13(3):152-7. PubMed ID: 3498115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acute increases in bone matrix degradation on circulating levels of bone-Gla protein.
    Riggs BL; Tsai KS; Mann KG
    J Bone Miner Res; 1986 Dec; 1(6):539-42. PubMed ID: 3509744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of bone gamma-carboxyglutamic acid-containing protein in plasma of healthy aging subjects.
    Catherwood BD; Marcus R; Madvig P; Cheung AK
    Bone; 1985; 6(1):9-13. PubMed ID: 3873250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
    Charles P; Poser JW; Mosekilde L; Jensen FT
    J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A radioimmunoassay for bone Gla protein (BGP) in human plasma.
    Johansen JS; Mølholm Hansen JE; Christiansen C
    Acta Endocrinol (Copenh); 1987 Mar; 114(3):410-6. PubMed ID: 3494371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease.
    Duda RJ; O'Brien JF; Katzmann JA; Peterson JM; Mann KG; Riggs BL
    J Clin Endocrinol Metab; 1988 May; 66(5):951-7. PubMed ID: 3258870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteocalcin].
    Galli M; Caniggia M
    Minerva Med; 1984 Nov; 75(42):2489-501. PubMed ID: 6334818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperparathyroidism is responsible for the increased levels of osteocalcin in patients with normally functioning kidney grafts.
    Amado JA; Riancho JA; De Francisco AL; Cotorruelo JG; Feijanes J; Arias M; Napal J; González-Macías J
    Nephron; 1989; 52(3):209-15. PubMed ID: 2662046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum osteocalcin (BGP) in tumor-associated hypercalcemia.
    Body JJ; Cleeren A; Pot M; Borkowski A
    J Bone Miner Res; 1986 Dec; 1(6):523-7. PubMed ID: 3509743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bone Gla-protein in renal osteodystrophy: comparison with bone histomorphometry.
    Charhon SA; Delmas PD; Malaval L; Chavassieux PM; Arlot M; Chapuy MC; Meunier PJ
    J Clin Endocrinol Metab; 1986 Oct; 63(4):892-7. PubMed ID: 3488998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in plasma bone GLA protein during treatment of bone disease.
    Deftos LJ; Parthemore JG; Price PA
    Calcif Tissue Int; 1982 Mar; 34(2):121-4. PubMed ID: 6805917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum bone Gla-protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor I, and serum testosterone.
    Johansen JS; Giwercman A; Hartwell D; Nielsen CT; Price PA; Christiansen C; Skakkebaek NE
    J Clin Endocrinol Metab; 1988 Aug; 67(2):273-8. PubMed ID: 3260598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum bone Gla protein: a marker of bone turnover in hyperthyroidism.
    Garrel DR; Delmas PD; Malaval L; Tourniaire J
    J Clin Endocrinol Metab; 1986 May; 62(5):1052-5. PubMed ID: 3485649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary epidermal growth factor excretion is correlated to renal function loss per se and not to the degree of diabetic renal failure.
    ter Meulen CG; Bilo HJ; van Kamp GJ; Gans RO; Donker AJ
    Neth J Med; 1994 Jan; 44(1):12-7. PubMed ID: 8202200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
    Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Separation and purefied of calf osteocalcin, set up radioimmunoassay for osteocalcin].
    Kong Y; Meng X; Zhou X; Liu H; Liu S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):257-62. PubMed ID: 10453563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.